India has set ambitious goals for its pharmaceutical sector: becoming the "pharmacy of the world" for generic medicines, expanding into complex generics and biosimilars, and boosting exports to $50 billion…
On August 25, 2026, India's Central Bureau of Narcotics (CBN) and the Pharmacy Export Promotion Council of India (PHARMEXCIL) signed a Memorandum of Understanding (MoU) to strengthen regulatory oversight of…
India's pharmaceutical regulatory framework has undergone significant transformation in recent years, with the Central Drugs Standard Control Organisation (CDSCO) and the Pharmacovigilance Programme of India (PvPI) playing increasingly active roles…
India's Central Drugs Standard Control Organisation (CDSCO) has flagged approximately 280 drug batches as Not of Standard Quality (NSQ) in its latest quality surveillance sweep, according to reports in The…